Managing Director @ Tianshi Capital (January 2011 - Present)
Director @ Haoyisheng.com (January 2000 - Present)
Founder @ Lysigen, a subsidiary of PrecisioBiotix (February 2020 - Present)
Founder @ Lysigen, a subsidiary of Precisio Biotix Therapeutics (February 2020 - Present)
Former Founder and Chairman @ Tiger Medical Group (January 2005 - December 2013)
Former Founder and Chairman @ Excel PharmaStudies (January 2000 - December 2009)
Mark Engel Education
Notre Dame
Mark Engel Skills
Life Sciences
Healthcare
Start-ups
Business Strategy
Commercialization
Strategic Planning
Pharmaceutical Industry
Clinical Trials
Medical Devices
Cross-functional Team Leadership
Business Development
Product Development
Biotechnology
Lifesciences
Process Improvement
FDA
Entrepreneurship
Team Building
Mergers & Acquisitions
Marketing Strategy
Mergers and Acquisitions
Cross Functional Team Leadership
Project Management
Marketing
Microsoft Office
Startups
Start Ups
Program Management
Mark Engel Summary
Mark Engel, based in United States, is currently a Chairman and CEO at Precisio Biotix Therapeutics. Mark Engel brings experience from previous roles at Precisio Biotix Therapeutics, Phagelux AgriHealth and Tianshi Capital. Mark Engel holds a Notre Dame. With a robust skill set that includes Life Sciences, Healthcare, Start-ups, Business Strategy, Commercialization and more. Mark Engel has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Mark Engel?
Find contact details for 700 million professionals.